Clinical Trial Update: Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating radiation therapy with cetuximab for advanced head and neck squamous cell carcinoma was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: TERMINATED | Results posted: 2021-01-20